hrcak mascot   Srce   HID

Stručni rad

The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?

Anton Sculean
Adrian Kašaj
Britta Willershausen

Puni tekst: engleski, pdf (78 KB) str. 223-228 preuzimanja: 556* citiraj
APA 6th Edition
Sculean, A., Kašaj, A. i Willershausen, B. (2004). The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?. Acta stomatologica Croatica, 38 (3), 223-228. Preuzeto s https://hrcak.srce.hr/1493
MLA 8th Edition
Sculean, Anton, et al. "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?." Acta stomatologica Croatica, vol. 38, br. 3, 2004, str. 223-228. https://hrcak.srce.hr/1493. Citirano 27.11.2021.
Chicago 17th Edition
Sculean, Anton, Adrian Kašaj i Britta Willershausen. "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?." Acta stomatologica Croatica 38, br. 3 (2004): 223-228. https://hrcak.srce.hr/1493
Harvard
Sculean, A., Kašaj, A., i Willershausen, B. (2004). 'The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?', Acta stomatologica Croatica, 38(3), str. 223-228. Preuzeto s: https://hrcak.srce.hr/1493 (Datum pristupa: 27.11.2021.)
Vancouver
Sculean A, Kašaj A, Willershausen B. The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?. Acta stomatologica Croatica [Internet]. 2004 [pristupljeno 27.11.2021.];38(3):223-228. Dostupno na: https://hrcak.srce.hr/1493
IEEE
A. Sculean, A. Kašaj i B. Willershausen, "The Application of Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: Which Applications are Evidence Based?", Acta stomatologica Croatica, vol.38, br. 3, str. 223-228, 2004. [Online]. Dostupno na: https://hrcak.srce.hr/1493. [Citirano: 27.11.2021.]
Puni tekst: hrvatski, pdf (90 KB) str. 215-222 preuzimanja: 579* citiraj
APA 6th Edition
Sculean, A., Kašaj, A. i Willershausen, B. (2004). Primjena proteinskog derivata matriksa cakline (Emdogain®) pri regenerativnom liječenju parodonta: koji se oblici primjene zasnivaju na dokazima?. Acta stomatologica Croatica, 38 (3), 215-222. Preuzeto s https://hrcak.srce.hr/1493
MLA 8th Edition
Sculean, Anton, et al. "Primjena proteinskog derivata matriksa cakline (Emdogain®) pri regenerativnom liječenju parodonta: koji se oblici primjene zasnivaju na dokazima?." Acta stomatologica Croatica, vol. 38, br. 3, 2004, str. 215-222. https://hrcak.srce.hr/1493. Citirano 27.11.2021.
Chicago 17th Edition
Sculean, Anton, Adrian Kašaj i Britta Willershausen. "Primjena proteinskog derivata matriksa cakline (Emdogain®) pri regenerativnom liječenju parodonta: koji se oblici primjene zasnivaju na dokazima?." Acta stomatologica Croatica 38, br. 3 (2004): 215-222. https://hrcak.srce.hr/1493
Harvard
Sculean, A., Kašaj, A., i Willershausen, B. (2004). 'Primjena proteinskog derivata matriksa cakline (Emdogain®) pri regenerativnom liječenju parodonta: koji se oblici primjene zasnivaju na dokazima?', Acta stomatologica Croatica, 38(3), str. 215-222. Preuzeto s: https://hrcak.srce.hr/1493 (Datum pristupa: 27.11.2021.)
Vancouver
Sculean A, Kašaj A, Willershausen B. Primjena proteinskog derivata matriksa cakline (Emdogain®) pri regenerativnom liječenju parodonta: koji se oblici primjene zasnivaju na dokazima?. Acta stomatologica Croatica [Internet]. 2004 [pristupljeno 27.11.2021.];38(3):215-222. Dostupno na: https://hrcak.srce.hr/1493
IEEE
A. Sculean, A. Kašaj i B. Willershausen, "Primjena proteinskog derivata matriksa cakline (Emdogain®) pri regenerativnom liječenju parodonta: koji se oblici primjene zasnivaju na dokazima?", Acta stomatologica Croatica, vol.38, br. 3, str. 215-222, 2004. [Online]. Dostupno na: https://hrcak.srce.hr/1493. [Citirano: 27.11.2021.]

Sažetak
The goal of regenerative periodontal therapy is the reconstitution of the lost periodontal structures (i.e. the new formation of root cementum, periodontal ligament and alveolar bone). Results from basic research have pointed to the important role of the enamel matrix protein derivative (EMD) in periodontal wound healing. Histological results of experiments in animals and of human case reports have shown that treatment with EMD promotes periodontal regeneration. Moreover, clinical studies have indicated that treatment with EMD positively influences periodontal wound healing in humans. The goal of the current overview is to present, based on the existing evidence, the clinical indications for regenerative therapy with EMD.

Ključne riječi
enamel matrix protein derivative; cementogenesis; surgical periodontal therapy; periodontal regeneration

Hrčak ID: 1493

URI
https://hrcak.srce.hr/1493

[hrvatski]

Posjeta: 1.837 *